One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The renal heading covers adults and children aged at least 3 months weighing more than 40 kg; it is not a small-child or neonatal schedule. The source also specifies additional doses both during and at the end of hemodialysis.
What to reconcile: Confirm population and local dialysis protocol. Do not silently change the source schedule.
Open this note and its source referencesGalway uses indexed eGFR and inpatient IV/PO ranges, whereas UCSF provides indication-specific oral CrCl schedules and specified dialysis assumptions. The printed UCSF headings leave exactly 30 unassigned. These protocols are not interchangeable.
What to reconcile: Resolve the printed boundary and match the indication, oral route and actual dialysis prescription.
Open this note and its source referencesConfirm the adult context and the unusual during-plus-end dialysis wording; do not silently substitute a different institutional schedule.
Dialysis evidence: A regimen is reported in selected content
The selected adult/severe-renal paragraph uses GFR in mL/min. Do not use the 875 mg strength below 30.
| GFR / treatment | Selected source regimen |
|---|---|
| 10-30 mL/min | 250 or 500 mg every 12 hours, selected by infection severity |
| Below 10 mL/min | 250 or 500 mg every 24 hours, selected by infection severity |
| Hemodialysis | 250 or 500 mg every 24 hours, with an additional dose both during and at the end of dialysis |
The renal heading covers adults and pediatric patients aged at least 3 months weighing more than 40 kg. It is not a neonatal or small-child renal table. The under-12-week section supplies no renal-impairment recommendation. Confirm age, weight, indication and formulation.
RDM61-rxlist-amoxicillin-40a112ae58-C1 · Source locator: Dosage and Administration: renal impairment; named precautions
No new official-label card was obtained for this product in v6.1. Earlier source layers, if present, were retained but not rechecked.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=amoxicillin&s1=RDM61-rxlist-amoxicillin-40a112ae58&h1=c4ca5bd9bb2274c36faa6d86ae2a2e64f66c40672690d6db8a504f210add868e